Amberlite XAD4离子交换大孔吸附树脂 37380-42-0
Amberlite XAD4离子交换大孔吸附树脂 37380-42-0
Amberlite XAD4离子交换大孔吸附树脂 37380-42-0
Amberlite XAD4离子交换大孔吸附树脂 37380-42-0

Amberlite XAD4离子交换大孔吸附树脂 37380-42-0

参考价: 面议

具体成交价以合同协议为准
2024-01-09 16:14:12
1097
产品属性
关闭
上海谷研实业有限公司

上海谷研实业有限公司

中级会员10
收藏

组合推荐相似产品

产品简介

我们为客户提供产品信息,Amberlite XAD4离子交换大孔吸附树脂 37380-42-0*,质量有保证。请您在交易过程中详细确认,并向我们销售人员确认购买方式,咨询!

详细介绍

公司专业销售生化试剂,氨基酸类,酶类,蛋白质类,植物激素及核酸类,碳水化合物类,色素类,缓冲剂类,培养基类,涉及到分析科学,生命科学,化学,材料科学。了解更多产品!
Amberlite XAD4离子交换大孔吸附树脂 37380-42-0Amberlite XAD4离子交换大孔吸附树脂/Amberlite XAD4    BR,20-60目    00克    ,Sigma-Aldrich、Amresco、Amersham、Serva、AppliChem等品牌,    37380-42-0    RT
500克    ,Sigma-Aldrich、Amresco、Amersham、Serva、AppliChem等品牌,

产品名称Amberlite XAD4离子交换大孔吸附树脂 37380-42-0
英文名称37380-42-0
规格可接受大包订制

中文名称:     
英文名称: 37380-42-0    
产品规格: BR,20-60目     
包装:500毫升     
:37380-42-0    
级别:BR    
Autoignition temp:800 °F    
Matrix:styrene-divinylbenzene    
Particle size :20~60 mesh    
Pore size:~0.98mL/g pore volume;40 Å mean pore size    
Surface area:725 m2/g    
Density:.02 g/mL at 25℃(true wet);.08 g/mL at 25℃(skeletal)    
性状:玻璃粉,大孔酚醛系吸附树脂。易于吸附大分子量的水溶性有机物    
用途:生化研究。吸附树脂用于去除蛋白、高分子量着色剂、有机杂质。用于纯化药物方面的具体应用如下:氨基酸和生物碱类物质的脱色、蛋白质去苦味、酶载体;提取蛋白质、多肽和动植物有效成份;水解:脱色、除去蛋白质、杂质离子,糠醛等会影响口味的离子;有机酸:脱色(发酵法有机酸,如柠檬酸、乳酸)    
保存:RT
是我司的优势产品,在行业中获得许多客户的赞誉。平易的价格,让您补足实验“粮响”。我司专业供应科研实验试剂,保质保量。严格操作,技术成熟。科研博大精深,学科之间相互渗透,我们以满足客户需求为己任,力求全面服务于新老客户。

aminoethyl]-benzenemethanol
L-Norpseudoephedrine (5 mg)    (-)-Norpseudoephedrine; (αR)-α-[(R)--aminoethyl]-benzenemethanol
L-Norpseudoephedrine (50 mg)    (-)-Norpseudoephedrine; (αR)-α-[(R)--aminoethyl]-benzenemethanol
Alprenolol (hydrochloride) (00 mg)    H 56/28; -[(-methylethyl)amino]-3-[2-(2-propen--yl)phenoxy]-2-propanol, monohydrochloride
Alprenolol (hydrochloride) (25 mg)    H 56/28; -[(-methylethyl)amino]-3-[2-(2-propen--yl)phenoxy]-2-propanol, monohydrochloride
Alprenolol (hydrochloride) (250 mg)    H 56/28; -[(-methylethyl)amino]-3-[2-(2-propen--yl)phenoxy]-2-propanol, monohydrochloride
Alprenolol (hydrochloride) (50 mg)    H 56/28; -[(-methylethyl)amino]-3-[2-(2-propen--yl)phenoxy]-2-propanol, monohydrochloride
Metolazone (0 mg)    SR 720-22|Zaroxolyn; 7-chloro-,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
Metolazone (00 mg)    SR 720-22|Zaroxolyn; 7-chloro-,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
Metolazone (25 mg)    SR 720-22|Zaroxolyn; 7-chloro-,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
Metolazone (50 mg)    SR 720-22|Zaroxolyn; 7-chloro-,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide
7-methyl Guanosine (00 mg)    7-
7-methyl Guanosine (25 mg)    7-
7-methyl Guanosine (250 mg)    7-
7-methyl Guanosine (50 mg)    7-
Lofexidine (hydrochloride) ( g)    2-[-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-H-imidazole, monohydrochlorideSR 555 (hydrochloride) (5 mg)    -(4-((4’-(,,,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-[,’-biphenyl]-4-yl)methyl)piperazin--yl)ethanone, monohydrochloride; SR 555 (hydrochloride)
SR 3335 ( mg)    N-[4-[2,2,2-trifluoro--hydroxy--(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide; ML 76; SR 3335
SR 3335 (0 mg)    N-[4-[2,2,2-trifluoro--hydroxy--(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide; ML 76; SR 3335
SR 3335 (25 mg)    N-[4-[2,2,2-trifluoro--hydroxy--(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide; ML 76; SR 3335
SR 3335 (5 mg)    N-[4-[2,2,2-trifluoro--hydroxy--(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide; ML 76; SR 3335
Canertinib (hydrochloride) (0 mg)    N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide, dihydrochloride; CI 033|PD 83805; Canertinib (hydrochloride)
Canertinib (hydrochloride) (25 mg)    N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide, dihydrochloride; CI 033|PD 83805; Canertinib (hydrochloride)
Canertinib (hydrochloride) (5 mg)    N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide, dihydrochloride; CI 033|PD 83805; Canertinib (hydrochloride)
Canertinib (hydrochloride) (50 mg)    N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide, dihydrochloride; CI 033|PD 83805; Canertinib (hydrochloride)
-hydroxy Vitamin D2 ( mg)    4-methylene-5Z-[2E-[(R,3aS)-octahydro-7aR-methyl-R-[R,4,5-trimethyl-2E-hexen--yl]-4H-inden-4-ylidene]ethylidene]-,3S-cyclohexanediol; -Hydroxyergocalciferol|Hectorol|TSA 840|Doxercalciferol; -hydroxy Vitamin D2

上一篇:组织培养用水的配制及保存的注意事项 下一篇:工业安全柜优异功能分析
热线电话 在线询价
提示

请选择您要拨打的电话:

温馨提示

该企业已关闭在线交流功能